Manufacturer mismatch does not affect patient outcomes in primary reverse shoulder arthroplasty
Mixing of glenoid and humeral components from different manufacturers does not appear to affect patient outcomes in primary RSA at 2 years follow-up. The results may provide valuable information for orthopedic surgeons when selecting the appropriate implant components for RSA and help guide clinical decision-making for better patient outcomes. It appears reasonable to have manufacturer mismatch when appropriate matching of implant material and curvature at a given diameter is used.
Authors
- Jeanni Zbinden (ORCID: https://orcid.org/0000-0002-1633-3243)
- Alaa Elsenbsy (ORCID: https://orcid.org/0000-0003-0081-0575)
- Marko Nabergoj (ORCID: https://orcid.org/0000-0001-6709-2139)
- Arash Amiri (ORCID: https://orcid.org/0009-0006-8451-7294)
- Philippe Collin (ORCID: https://orcid.org/0000-0002-8974-7156)
- Alexandre Lädermann (ORCID: https://orcid.org/0000-0002-2797-8936)
- Austin F. Smith (ORCID: https://orcid.org/0000-0002-3107-8455)
Institutions
- Hôpital américain de paris (FR)
- University of Kansas (US)
- South Valley University (EG)
- Shiraz University of Medical Sciences (IR)
- Orthopaedic Hospital Valdoltra (SI)
- Centre Hospitalier privé Saint Grégoire (FR)
- Clinique Victor Hugo (FR)
- Hôpital de la Tour (CH)
Publication Details
- Journal
- Journal of Shoulder and Elbow Surgery
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1016/j.jse.2024.10.001
- Citations
- 2
- Primary Topic
- Shoulder Injury and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.15